Colonic inflammation in Parkinson's disease D Devos, T Lebouvier, B Lardeux, M Biraud, T Rouaud, H Pouclet, ... Neurobiology of disease 50, 42-48, 2013 | 634 | 2013 |
Targeting chelatable iron as a therapeutic modality in Parkinson's disease D Devos, C Moreau, JC Devedjian, J Kluza, M Petrault, C Laloux, ... Antioxidants & redox signaling 21 (2), 195-210, 2014 | 613 | 2014 |
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC B Do Van, F Gouel, A Jonneaux, K Timmerman, P Gelé, M Pétrault, ... Neurobiology of disease 94, 169-178, 2016 | 611 | 2016 |
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease P Sockeel, K Dujardin, D Devos, C Denève, A Destée, L Defebvre Journal of Neurology, Neurosurgery & Psychiatry 77 (5), 579-584, 2006 | 609 | 2006 |
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease C Moreau, L Defebvre, A Destée, S Bleuse, F Clement, JL Blatt, ... Neurology 71 (2), 80-84, 2008 | 419 | 2008 |
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration S Masaldan, AI Bush, D Devos, AS Rolland, C Moreau Free Radical Biology and Medicine 133, 221-233, 2019 | 384 | 2019 |
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double‐blind, randomized, placebo‐controlled study D Devos, K Dujardin, I Poirot, C Moreau, O Cottencin, P Thomas, ... Movement Disorders 23 (6), 850-857, 2008 | 334 | 2008 |
Characteristics of apathy in Parkinson's disease K Dujardin, P Sockeel, D Devos, M Delliaux, P Krystkowiak, A Destée, ... Movement Disorders 22 (6), 778-784, 2007 | 316 | 2007 |
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease L Mahoney-Sánchez, H Bouchaoui, S Ayton, D Devos, JA Duce, ... Progress in neurobiology 196, 101890, 2021 | 313 | 2021 |
Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care Y Wang, P Spincemaille, Z Liu, A Dimov, K Deh, J Li, Y Zhang, Y Yao, ... Journal of magnetic resonance imaging 46 (4), 951-971, 2017 | 279 | 2017 |
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease D Devos, French DUODOPA Study Group Movement Disorders 24 (7), 993-1000, 2009 | 254 | 2009 |
Study of circadian melatonin secretion pattern at different stages of Parkinson's disease R Bordet, D Devos, S Brique, Y Touitou, JD Guieu, C Libersa, A Destee Clinical neuropharmacology 26 (2), 65-72, 2003 | 231 | 2003 |
Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine T Burnouf, HA Goubran, ML Chou, D Devos, M Radosevic Blood reviews 28 (4), 155-166, 2014 | 228 | 2014 |
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo … C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ... The lancet neurology 11 (7), 589-596, 2012 | 219 | 2012 |
Elevated IL-6 and TNF-α levels in patients with ALS: inflammation or hypoxia? C Moreau, D Devos, V Brunaud-Danel, L Defebvre, T Perez, A Destee, ... Neurology 65 (12), 1958-1960, 2005 | 170 | 2005 |
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial D Devos, C Moreau, D Maltête, R Lefaucheur, A Kreisler, A Eusebio, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (6), 668-674, 2014 | 169 | 2014 |
Brief and sustained movements: differences in event-related (de) synchronization (ERD/ERS) patterns F Cassim, W Szurhaj, H Sediri, D Devos, JL Bourriez, I Poirot, ... Clinical neurophysiology 111 (11), 2032-2039, 2000 | 164 | 2000 |
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease D Devos, P Krystkowiak, F Clement, K Dujardin, O Cottencin, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (5), 470-475, 2007 | 159 | 2007 |
Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis N Carriere, P Besson, K Dujardin, A Duhamel, L Defebvre, C Delmaire, ... Movement disorders 29 (7), 897-903, 2014 | 156 | 2014 |
A specific clinical pattern of camptocormia in Parkinson’s disease AC Lepoutre, D Devos, A Blanchard-Dauphin, V Pardessus, CA Maurage, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (11), 1229-1234, 2006 | 156 | 2006 |